Andrea Passalacqua News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Andrea passalacqua. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Andrea Passalacqua Today - Breaking & Trending Today

Oncopeptides strengthens leadership in Europe and opens an Early Access Program in multiple myeloma


Oncopeptides strengthens leadership in Europe and opens an Early Access Program in multiple myeloma
News provided by
Share this article
STOCKHOLM, March 8, 2021 /PRNewswire/  Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO
), a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, today announced that it strengthens the leadership of the European operations by appointing Andrea Passalacqua as General Manager in Europe, and Pamela Bacon as Head of Medical Affairs Europe. The Company also announced that it opens an Early Access Program across Europe to address the significant need of new treatment alternatives in multiple myeloma. As previously announced, Oncopeptides will also seek a Conditional Marketing Authorization of melphalan flufenamide in triple class refractory multiple myeloma, during second quarter of 2021. ....

United States , Paula Boultbee , Andrea Passalacqua , Martyj Duvall , Rolf Gulliksen , Linda Holmstr , Oncopeptides Inc , Global Head Of Corporate Communications , Early Access Program , Global Head Of Medical Affairs , Leadership Team Of Oncopeptides , Head Of Medical Affairs In Europe , Early Access Program In Europe , European Medicines Agency , Access Program , Nasdaq Stockholm , General Manager , Pamela Bacon , Medical Affairs , Conditional Marketing Authorization , Chief Executive Officer , Leadership Team , Key Opinion Leaders , Clinical Oncology , Expanded Access Program , Sofia Heigis ,